In our in vivo experiments, we further confirmed that TAM-EVs enhanced HNSCC angiogenesis and tumor growth through the miR-21-5p/YAP1/HIF-1α axis. This evidence concerns the gene HIF1A and head and neck squamous cell carcinoma.